LYSMD2 inhibitors are a class of chemical compounds that target the LysM domain-containing protein 2 (LYSMD2), which is part of the LysM (lysin motif) domain-containing protein family. The LysM domain is a conserved protein module that binds to carbohydrate structures, particularly peptidoglycan, which is a key component of bacterial cell walls. LYSMD2, a protein with yet-to-be-fully-clarified biological functions, is known to interact with specific molecular patterns that are involved in cellular recognition processes. Inhibitors of LYSMD2 function by modulating the interactions of this protein with its binding partners, typically by obstructing its ability to recognize and bind to carbohydrate or protein substrates. This modulation can result in alterations to cellular signaling pathways that LYSMD2 is involved in, impacting its physiological roles in the cell.
These inhibitors are of significant interest in the field of biochemical research because they offer insights into how LysM domain-containing proteins contribute to cellular processes such as immune response regulation, cell wall maintenance, and host-pathogen interactions. Structurally, LYSMD2 inhibitors can vary widely, with some compounds designed to mimic the natural ligands that bind to the LysM domain, while others are more general modulators that interfere with the protein's function by targeting other regions essential for its activity. These inhibitors are valuable tools for dissecting the functional roles of LYSMD2 in various biological systems and understanding how it contributes to the broader network of protein-carbohydrate interactions in cellular processes. Detailed structural studies of LYSMD2 inhibitors are essential for elucidating the binding affinities, structural conformations, and potential regulatory mechanisms that govern LysM domain-mediated interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Found in Gram-negative bacteria, might indirectly affect LYSMD2 through immune system modulation. | ||||||
N-Acetyl-D-glucosamine | 7512-17-6 | sc-286377 sc-286377B sc-286377A | 50 g 100 g 250 g | $94.00 $162.00 $306.00 | 1 | |
A monosaccharide forming chitin, could interact with LysM domains and affect LYSMD2. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, potentially affecting LYSMD2 by altering glycoprotein synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis in eukaryotes, could indirectly influence LYSMD2 activity. | ||||||
Collagen IV | sc-29010 | 1 mg | $224.00 | 11 | ||
A major component of bacterial cell walls, potentially impacting LYSMD2 when interacting with LysM domains. | ||||||
Penicillin G sodium salt | 69-57-8 | sc-257971 sc-257971A sc-257971B sc-257971C sc-257971D | 1 mg 10 mg 1 g 5 g 100 g | $26.00 $37.00 $47.00 $171.00 $265.00 | 1 | |
Inhibits bacterial cell wall synthesis, could indirectly affect LYSMD2 through its impact on bacteria. | ||||||